Stem Cell Sciences Plc STEM Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BIONET Corp. SWOT Analysis report provides you a strategic analysis ...

Industries: Biological Therapy | Countries: Taiwan

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the research and development (R&D) of novel immunotherapies for the treatment of cancer. The company's key product, MyVax personalized immunotherapy is currently in a pivotal phase 3 trial fo ...

Industries: Biological Therapy | Countries: United States

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and immune system recovery. The company focuses on identifying chemokines and their associated receptors ...

Industries: Biological Therapy | Countries: Canada, United Kingdom

Japan Tissue Engineering Co., Ltd. (Symbol:7774) SWOT Analysis, Strategy, Revenues and Profits

Japan Tissue Engineering Co., Ltd. (Symbol:7774) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Japan Tissue Engineering Co., Ltd. SWOT Analysis report provides you ...

Industries: Biological Therapy | Countries: Japan

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. MediPost Co., Ltd. SWOT Analysis report provides you a strategic analysis ...

Industries: Biological Therapy

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. TiGenix NV SWOT Analysis report provides you a strategic analysis ...

Industries: Biological Therapy | Countries: Belgium, Spain

Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Tissue Therapies Limited SWOT Analysis report provides you a strategic ...

Industries: Biological Therapy | Countries: Australia

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company's services include cell therapy. Its cell therapy is developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized ...

Industries: Biological Therapy | Countries: United States

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Forticell Bioscience, Inc. (Forticell) is a biotechnology company. The company develops natural biomaterials and tissue engineered cellular therapies. Its product OrCel is used to stimulate the repair and regeneration of human skin. The company's product is developed for people with venous stasis ...

Industries: Biological Therapy | Countries: United States

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Vita 34 International AG (Vita 34) is a pharmaceutical company. The company collects, prepares, processes, and stores stem cells from umbilical cord blood. Its products include vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vitapluscordtissue25, and vitapluscordtissue50. Vita 34 research ...

Industries: Biological Therapy | Countries: Switzerland

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.